💊#FDA Approval Update | #Lynkuet® (#elinzanetant) is now approved for moderate to severe menopausal hot flashes — the first dual #NK1,3 receptor antagonist.
⚙️By blocking NK1,3 signaling on #KNDy neurons, it helps regulate thermoregulation and reduce hot flashes.
✔️Backed by Phase III OASIS trials
Translating KNDy Neuron Biology into New Therapies webinar | On Wednesday, April 30 at 12:00–1:00 PM ET, learn about novel therapeutics to treat post-menopausal hot flushes as well as other reproductive disorders. Register now: bit.ly/4lyIGAe #neuroendocrinology #hotflashes #postmenopause #KNDy
Suffolk ewes
As small bit of good news for these times, happy to report Casey Nestor and I received notice of award from NICHD of our new 5 yr R01 grant to continue work on #KNDy cells in #sheep! Team includes co-Is Rick McCosh, Lique Coolen & Bob G., Stan Hileman @jne-editor.bsky.social @paneuroendo.bsky.social
